SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Total Non-Current Liabilities (2021 - 2026)

SeaStar Medical Holding's (ICU) quarterly Total Non-Current Liabilities came in at $3.9 million in Q1 2026, down 43.86% YoY from $7.0 million in Q1 2025, and up 5.53% on a QoQ basis from $3.7 million in Q4 2025.

SeaStar Medical Holding (ICU) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 6 years of Total Non-Current Liabilities data on file, last reported at $3.9 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 43.86% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 43.86% YoY) and the FY2025 annual result came in at $3.7 million, down 45.05% from the prior year.
  • Total Non-Current Liabilities improved to $3.9 million in Q1 2026, from $3.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $27.0 million in Q1 2023 to a low of $3.7 million in Q4 2025.
  • A 5-year average of $9.6 million and a median of $6.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 607.49% — and 2024, when it tumbled 54.84%.
  • Tracing ICU's Total Non-Current Liabilities over 5 years: stood at $23.8 million in 2022, then plunged by 36.66% to $15.1 million in 2023, then plunged by 54.84% to $6.8 million in 2024, then plunged by 45.05% to $3.7 million in 2025, then grew by 5.53% to $3.9 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $3.9 million (Q1 2026), $3.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 40.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 724.15 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.17 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.32 Bn
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 4.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.35 Mn
Mar 31, 2026 3.95 Mn
Dec 31, 2025 3.74 Mn
Sep 30, 2025 4.07 Mn
Jun 30, 2025 5.04 Mn
Mar 31, 2025 7.03 Mn
Dec 31, 2024 6.81 Mn
Sep 30, 2024 6.64 Mn
Jun 30, 2024 10.37 Mn
Mar 31, 2024 12.21 Mn
Dec 31, 2023 15.08 Mn
Mar 31, 2023 27.02 Mn
Dec 31, 2022 23.80 Mn
Sep 30, 2022 8.26 Mn
Jun 30, 2022 5.57 Mn
Mar 31, 2022 4.24 Mn
Dec 31, 2021 3.36 Mn
Sep 30, 2021 3.90 Mn
Jun 30, 2021 3.81 Mn
Mar 31, 2021 3.91 Mn